![Virtual Booth](https://www.pharmacompass.com/image/vb/vb-orange-btn.png)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-desktop-w27gif-57924.gif)
![Minakem Generic APIs](https://www.pharmacompass.com/image/flap/minakem-header-mobile-w27gif-62411.gif)
X
20
Concord Biotech Limited Ahmedabad In, based in India, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
One of their significant offerings is Ciclosporin, supported by a 'Valid' Certificate of Suitability (CEP) with the number R1-CEP 2010-214 - Rev 03
This Chemical Type CEP, issued on October 17, 2022, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 994 associated with this CEP further emphasizes